CDKN1A and hepatocellular carcinoma: Similarly, we confirmed that FBXO22 interacts with p53 or p21 individually, which supports the hypothesis that FBXO22 might regulate cell proliferation by targeting the degradation of the p53/p21 complex in HCC.